Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months

SARS-CoV-2 vaccines have shown very high effectiveness in real-world scenarios. However, there is compelling evidence for a fast-paced waning of immunity. The increasing number of new variants that could alter the severity, transmissibility, and potential to evade the immune response raised signific...

Full description

Autores:
Lopera, Tulio J.
Chvatal-Medina, Mateo
Flórez-Álvarez, Lizdany
Zapata-Cardona, Maria I.
Taborda, Natalia A.
Rugeles, Maria T.
Hernández López, Juan Carlos
Tipo de recurso:
Article of investigation
Fecha de publicación:
2022
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/45974
Acceso en línea:
https://hdl.handle.net/20.500.12494/45974
Palabra clave:
SARS-CoV-2
vaccine
neutralizing antibodies
immunity
immunogenicity
variant
Rights
openAccess
License
Atribución